| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971170 | The Journal of Heart and Lung Transplantation | 2012 | 9 Pages |
Abstract
Marked elevation of osteopontin levels before LVAD placement is associated with RVF development. Persistent elevation of circulating ECM markers after LVAD implantation characterizes patients who develop RVF. These novel biomarkers would have a potential role in the prediction of RVF development in patients undergoing LVAD implantation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tomoko S. MD, PhD, Aalap BS, Parvati BS, Tuba MD, Shinichi MD, PhD, Shunichi MD, Hirokazu MD, PhD, Faisal H. MD, Jonathan MD, Hiroo MD, PhD, Yoshifumi MD, PhD, Maryjane MD, Donna MD, P. Christian MD, PhD,